Strategy and activity discussion : retail price disclosure of prescription drugs / Bureau of Consumer Affairs. : RG23-130/1977E-PDF
"Adequate price disclosure, a major ingredient found in all other consumer purchasing decisions, is practically non-existent in the dispensing of prescription drugs and appears to severely restrict consumer choice and free market competition. In May, 1977, Mediaspec Inc. submitted "A Report on Prescription Drug Price Disclosure" commissioned by the Bureau of Consumer Affairs exploring this issue, and Consumer Services Branch, in collaboration with Consumer Research Branch, was asked to evaluate the findings and conceive a complete strategy for Bureau action. Based on our evaluation and investigation, and with the concurrence of Consumer Research Branch, this paper proposes what we believe to be the most desirable course of action for the Bureau"--Introduction.
Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.883880&sl=1
| Ministère/Organisme | Canada. Bureau of Consumer Affairs, issuing body. |
|---|---|
| Titre | Strategy and activity discussion : retail price disclosure of prescription drugs / Bureau of Consumer Affairs. |
| Type de publication | Monographie |
| Langue | [Anglais] |
| Format | Électronique |
| Document électronique | |
| Note(s) | Digitized edition from print [produced by Innovation, Science and Economic Development Canada]. |
| Information sur la publication | [Ottawa] : [Consumer and Corporate Affairs Canada], September 16, 1977. |
| Description | 1 online resource (1 volume (various pagings)) : charts |
| Numéro de catalogue |
|
| Descripteurs | Drugs -- Prices -- Canada. Médicaments -- Prix -- Canada. |
Demander des formats alternatifs
Pour demander une publication dans un format alternatif, remplissez le formulaire électronique des publications du gouvernement du Canada. Utilisez le champ du formulaire «question ou commentaire» pour spécifier la publication demandée.- Date de modification :